Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Isoplexis Corp.
Headquarters: Branford, CT, United States of America
Website: N/A
Year Founded: 2013
Status: Acquired
BioCentury | Dec 24, 2022
BioCentury Commentary
Noisemakers and newsmakers of 2022, and hot takes for 2023
BioCentury’s analysts look back at a year when industry took some slings and arrows but delivered breakthroughs, and predict what’ll be hot in 2023
BioCentury | Dec 23, 2022
Deals
Dec. 22 Quick Takes: Mersana picks Merck KGaA for its third ADC deal of 2022
Plus: Lilly builds on genetic medicine focus with ProQR deal and Stifel buying Torreya; Gilead; lecanemab; ORIC-Pfizer and more
BioCentury | Oct 8, 2021
Finance
Nearing $30B in 2021, global biotech IPOs on pace to top record
IPOs by Pyxis, IsoPlexis and Cognition bring October’s tally to almost $900M in fresh paper
BioCentury | Jul 11, 2020
Management Tracks
Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more
BioCentury | May 16, 2020
Management Tracks
Management Tracks: Evox, Phoenix Tissue Repair, Artax, Nucleix, IsoPlexis, Centogene, Immunicum, CohBar and CorMedix
BioCentury | May 15, 2019
Financial News
May 15 Financial Quick Takes: Perceptive leads $60M round for ArcherDx; plus Applied Therapeutics’ IPO, IsoPlexis, Symphogen
Items per page:
1 - 8 of 8